{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.87 vs. cons $1.84",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.50B vs. cons $2.49B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic operational revenue growth",
      "prediction": "MISS",
      "answer": "pred ~1.0% vs. cons 1.6%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Revenue guidance",
      "prediction": "BETTER",
      "answer": "guide ~$9.76B vs. cons $9.72B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted diluted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$6.93 vs. cons $6.89 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic operational revenue growth guidance",
      "prediction": "LOWER",
      "answer": "guide ~3.0% vs. cons 3.3% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 4.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.7,
  "day5_path": "FADE",
  "day5_rationale": "Day-5 residual ~+1.7% vs. day-1 residual ~+4.8%: an EPS beat, stabilization signals and guidance numerically above consensus should drive initial relief, but a lower organic-growth midpoint and weaker implied second-half companion-animal trajectory should pull out-period estimates down and partially reverse the move.",
  "day5_confidence": "MEDIUM"
}